MENU Quick Go

  • HOME
  • About PharmAbcine
  • History
History

2008
Sep. PharmAbcine was established as a spin-off of government-funded research institute,
Korea Research Institute of Bioscience and Biotechnology (KRIBB).
Oct. PharmAbcine was awarded grand prix from 1st GATE project sponsored by Novartis
Venture Funds (NVF), Korea Trade-Investment Promotion Agency (KOTRA), Samsung
Electronics, Korea Health Industry Development Institute (KHIDI).
2008
Apr. PharmAbcine was granted from Ministry of Knowledge Education (MKE) (USD 1.4 MM/2 year)
Jun. PharmAbcine was granted from Small and Medium Business Administration (SMBA)
(USD 0.2 MM/3 year)
Aug. PharmAbcine closed Series A financing by OrbiMed, Novartis Venture Funds, Green Cross, Tong-Yang VC,
Sae-Han VC, etc. (USD 6 MM)
Dec. Establishment of Annex R & D Center for company
Dec. PharmAbcine was granted from Ministry of Health and Welfare (MOHW) (USD 1.1 MM/5 year)
Present
May. PharmAbcine was granted from Ministry of Health and Welfare (MOHW) (USD 0.9 MM/2 year)
Jun. PharmAbcine was granted from Ministry of Knowledge Education (MKE) (USD 2.2 MM/3 year)
Present
Present PharmAbcine is ready to submit TTAC-0001 IND document by 2011